TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
HSDT

Helius Medical Technologies Inc Class A

Financial Services · Asset Management

2.80$ -3.4% vs. previous close Closing price · As of: Sep 28, 2026

Ownership

Ownership Structure

Who owns Helius Medical Technologies Inc Class A (HSDT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 74.4% of the shares are freely tradable; institutional investors hold 27.4%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 27.4%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 22.3%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 74.4%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 2.0%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 61Mio.

Largest Shareholders

Institutions

Institutions HSDT
Name Stake (%) Shares Change (%) Date
Kathmere Capital Management, LLC 7.60 4,594,960 +0.0 06/30/2026
Pantera Capital Partners LP 6.43 3,887,319 +0.0 03/31/2026
Arrington Capital Management, LLC 1.09 658,908 +0.0 06/30/2026
VR Advisory Services Ltd 0.96 581,310 +0.0 03/31/2026
LPL Financial Corp 0.90 547,261 +43.2 03/31/2026
BlackRock Inc 0.76 461,202 +0.0 03/31/2026
Hel Ved Capital Management Ltd 0.72 435,983 +0.0 03/31/2026
Geode Capital Management, LLC 0.61 370,604 +6.5 03/31/2026
Rockefeller Capital Management L.P. 0.57 344,904 -22.5 03/31/2026
Vanguard Capital Management, LLC 0.54 324,551 +0.0 03/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?